SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011094
Filing Date
2022-06-02
Accepted
2022-06-02 17:15:54
Documents
12
Period of Report
2022-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lhdx-20220601.htm   iXBRL 8-K 77356
  Complete submission text file 0000950170-22-011094.txt   195055

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lhdx-20220601_lab.xml EX-101.LAB 13342
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lhdx-20220601_pre.xml EX-101.PRE 9848
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lhdx-20220601.xsd EX-101.SCH 2481
6 EXTRACTED XBRL INSTANCE DOCUMENT lhdx-20220601_htm.xml XML 4696
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 22991960
SIC: 2835 In Vitro & In Vivo Diagnostic Substances